Taxotere (docetaxel) is a drug produced and distributed by Sanofi-Aventis. It is used for chemotherapy and originally approved by the United States Food and Drug Administration in 1996. Since this time, the agency approved the drug for treating a number of different cancers. It is considered one of the most popular, and widely used drugs, for the treatment of breast cancer.
There are approximately three million women located in the U.S. alone who are living and dealing with breast cancer, in reference to stats from Breastcancer.org. In the year 2016 alone, approximately 300,000 additional women are going to be diagnosed with this disease. Taxotere is a drug used by many oncologists who are fighting breast cancer in women. In fact, some statistics state that as many as 75 percent of all women who have breast cancer are going to receive Taxotere during their treatment. In fact, according to the manufacturer, Sanofi, the drug is the top option prescribed in its class.
In a number of studies, Taxotere performed better than the other drugs available in regard to extending the survival of patients with breast cancer. However, many have found the drug may also cause an unpleasant side effect for those who survive breast cancer – permanent hair loss, also referred to as alopecia.
As a result of this side effect, the manufacturing company, Sanofi is facing a number of lawsuits, which has been filed by women who state the company never provided a warning regarding the severity and the permanence of the hair loss they would experience. Many women claim that if they were aware of the possibility of permanent alopecia, they may have chosen a different treatment path.
Much like other types of drugs used for chemotherapy, Taxotere works by prohibiting cells from dividing and duplicating. Any healthy, normal cell stops dividing if they are around other, similar cells. However, cancer cells are damaged, and as a result, cannot stop dividing. This is how cancer spreads. Drugs used for chemotherapy, such as Taxotere attach the RNA and the DNA in cancer cells so the tumor is no longer about to duplicate itself and continue to spread.
Even though chemotherapy is well known for causing hair loss, the majority of cases resolve within three to six months after treatment is complete. The fact is, that hair loss is considered one of the most distressing side effects of cancer treatment. Studies have even shown that this loss has a direct impact on a person’s quality of life, which means that permanent hair loss is often devastating.
There are studies that have shown that Taxotere can result in permanent and irreversible alopecia. This affects all hair on the body, including the pubic hair, eyelashes, and eyebrows.
If you are a victim of this problem and want to receive compensation for not being warned about the permanent side effects that Taxotere can cause, then call our attorneys today. We can help you recover the compensation you deserve.